Recombinant Human SRGN Protein，His

SRGN, or serglycin, is a novel protein that plays a crucial role in various biological processes, including cell adhesion, inflammation, and extracellular matrix organization. Research on SRGN has gained momentum due to its implications in several disease states, including cancer, autoimmune disorders, and infections. This proteoglycan is primarily expressed in hematopoietic cells and has been implicated in modulating the functions of these cells, notably in immune responses. The structure of SRGN allows it to interact with various proteins and growth factors, suggesting a multifaceted role in cellular communication and signaling pathways. Understanding the mechanisms by which SRGN contributes to disease progression is of significant interest, as it may unveil new therapeutic targets. Recent studies have highlighted its involvement in tumor microenvironments, where it may facilitate cancer cell survival and metastasis. Additionally, SRGN's potential as a biomarker for certain conditions is being explored, promising to enhance diagnostic and prognostic capabilities in clinical settings. Consequently, SRGN represents a critical area of research within the fields of molecular biology and medicine, with ongoing investigations aimed at elucidating its functional significance and therapeutic potential.